0001285819false00012858192020-06-052020-06-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 5, 2020

OMEROS CORPORATION

(Exact name of Registrant as Specified in Its Charter)

Washington

001-34475

91-1663741

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

201 Elliott Avenue West
Seattle, WA

 

98119

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (206) 676-5000

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered Pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.01 par value per share

OMER

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 under the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.07 Submission of Matters to a Vote of Security Holders.

Omeros Corporation (“Omeros” or the “Company”) held its 2020 Annual Meeting of Shareholders on June 5, 2020 (the “Annual Meeting”). Shareholders of record at the close of business on April 13, 2020 were entitled to vote 54,510,667 shares of common stock at the Annual Meeting. A total of 45,002,862 shares (82.6%) were represented at the Annual Meeting in person or by proxy. Set forth below is a brief description of each matter voted upon at the Annual Meeting and the final voting results for each matter.

(1)The following individuals were elected to serve as directors by the vote set forth below. Mr. Thomas J. Cable, Dr. Peter Demopulos, and Mr. Kurt Zumwalt were elected as Class II directors, each to serve until the 2023 Annual Meeting of Shareholders of Shareholders, or, in each case, until his successor is duly elected and qualified, or until his earlier death, resignation or removal.

For

Against

Abstain

Broker Non-Votes

Thomas J. Cable

20,663,275

6,762,866

461,617

17,115,104

Peter A. Demopulos, M.D.

25,790,712

1,745,633

351,413

17,115,104

Kurt Zumwalt

27,204,561

439,544

243,653

17,115,104

(2)Shareholders approved an advisory resolution regarding the compensation of Omeros’ named executive officers as reported in the proxy statement for the 2020 Annual Meeting of Shareholders by the vote set forth below.

For

Against

Abstain

Broker Non-Votes

25,967,469

1,316,736

603,553

17,115,104

(3)Shareholders ratified the appointment of Ernst & Young LLP as Omeros’ independent registered public accounting firm for the fiscal year ending December 31, 2019 by the vote set forth below.

For

Against

Abstain

Broker Non-Votes

43,923,851

661,300

417,711

17,115,104

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OMEROS CORPORATION

Date: June 11, 2020

By:

/s/ Gregory A. Demopulos

Gregory A. Demopulos, M.D.

President, Chief Executive Officer and

Chairman of the Board of Directors

v3.20.1
Document and Entity Information
Jun. 05, 2020
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Jun. 05, 2020
Entity Registrant Name OMEROS CORPORATION
Entity Central Index Key 0001285819
Entity Incorporation, State or Country Code WA
Entity File Number 001-34475
Entity Tax Identification Number 91-1663741
Entity Address, Address Line One 201 Elliott Avenue West
Entity Address, City or Town Seattle
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98119
City Area Code 206
Local Phone Number 676-5000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.01 par value per share
Trading Symbol OMER
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false